Enwave Corporation Stock
€0.19
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Enwave Corporation | -1.600% | -1.053% | 1.075% | -35.616% | -23.577% | -79.476% | -84.740% |
Promis Neurosciences Inc. | -5.060% | 10.559% | 3.488% | -67.928% | 78.894% | -76.171% | -83.426% |
InMed Pharmaceuticals Inc. | -12.200% | 0.756% | -17.620% | -74.473% | -22.529% | -99.537% | -99.891% |
Resverlogix Corp | - | 5.797% | 0.000% | -64.216% | -15.116% | -93.596% | -98.576% |
News
EnWave Signs Technology Evaluation and License Option Agreement with Food Company Led by Michelin Star Chef
Vancouver, B.C., April 2nd, 2024, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that it has signed a Technology Evaluation and License Option Agreement
EnWave Declares Significant Sales Wins for Royalty-Partner BranchOut Food
Vancouver, B.C., February 29th, 2024, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that BranchOut Food Inc. (NASDAQ:BOF) (“BranchOut”), a royalty
EnWave Signs Royalty-Bearing Commercial License with Established South American Food Manufacturer
Vancouver, B.C., February 28th, 2024 - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a new royalty-bearing commercial